What You'll Learn:
Eric Edmunds, JD, of The Acheson Group updates us on the regulatory changes triggered by the 2018 Farm Bill for hemp and CBD products and makes some insightful predictions about future FDA rulings based on the FDA’s handling of Epidiolex.